Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AmberHealth vs LIV by WellNow

AmberHealth
Graded #31

Higher grade

vs+20.000000000000007
LIV by WellNow
Graded #262

Lower grade

The verdict

AmberHealth takes it — 82.9/100 to 62.9/100.

AmberHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide nationwide, though tirzepatide runs $175 and it isn't verified.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAmberHealth +39
90
51
Dose & formulationAmberHealth +7
80
73
Clinical oversightEven
79
79
Labs & monitoringAmberHealth +26
78
52
FulfillmentAmberHealth +23
86
63
Contract termsAmberHealth +27
82
55
AmberHealth · left barLIV by WellNow · right bar

The numbers

MetricAmberHealthLIV by WellNow
WeighScore82.9/10062.9/100
GradeB−C
Scorecard rank#31#262
Semaglutide$100/mo$279/mo
Tirzepatide$175/moNot disclosed
CoverageAll 50 states5 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
AmberHealth

Graded #31 · B−

Strengths

  • $100 semaglutide
  • All 50 states
  • Both molecules

Where it loses points

  • Not LegitScript-verified
  • Tirzepatide $175
  • Monitoring detail sparse
LIV by WellNow

Graded #262 · C

Strengths

  • Flat $279/month covers medication, supplies, and unlimited virtual visits
  • Backed by established WellNow Urgent Care brand
  • Board-certified online medical providers
  • Same-day approval and monthly home delivery
  • Transparent all-inclusive pricing with no hidden fees

Where it loses points

  • Compounded semaglutide is not FDA-approved or evaluated
  • Only available in five states (IL, IN, MI, NY, PA)
  • No tirzepatide option offered
  • Insurance not accepted for compounded semaglutide

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard